Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001437749-25-038570
Filing Date
2025-12-22
Accepted
2025-12-22 17:27:46
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM PRER14A mbrx-20251231.htm   iXBRL PRER14A 134146
6 mb_page1.jpg GRAPHIC 127051
7 mb_page2.jpg GRAPHIC 117717
  Complete submission text file 0001437749-25-038570.txt   987327

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20251231.xsd EX-101.SCH 4575
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20251231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20251231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20251231_pre.xml EX-101.PRE 714
17 EXTRACTED XBRL INSTANCE DOCUMENT mbrx-20251231_htm.xml XML 1046
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37758 | Film No.: 251593563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)